The US-SCAP study was funded by Eli Lilly and Company and administered by the Medstat Group. The authors thank the site investigators and others who collaborated in the research. Maryland: Anthony F. Lehman, M.D., M.S.P.H., University of Maryland School of Medicine, and Gerard Gallucci, M.D., M.H.S., Johns Hopkins Bayview Medical Center (formerly). Colorado: Courtenay Harding, Ph.D., University of Colorado (formerly). Florida: David Shern, Ph.D., Florida Mental Health Institute, University of South Florida (formerly), and Terri Saunders, M.S. (formerly Florida Mental Health Institute). North Carolina: Jeffrey Swanson, Ph.D., Lawrence A. Dunn, M.D., and Marvin Swartz, M.D., Duke University Medical School. California: Richard L. Hough, Ph.D., and Concepcion Barrio, Ph.D., Child and Adolescent Services Research Center and San Diego State University. Connecticut: Robert A. Rosenheck, M.D., and Rani Desai, Ph.D., Department of Veterans Affairs Connecticut Health Care System. Medstat group: Pat Russo, Ph.D., M.S.W. (formerly), Liisa Palmer, Ph.D., Lito Torres, M.B.A., and Brian Cuffel, Ph.D. (formerly). Eli Lilly and Company: Don Buesching, Ph.D., Brian M. Johnstone, Ph.D., and Thomas Croghan, M.D. (formerly). Consultants: David Salkever, Ph.D. (formerly of Johns Hopkins University), Eric P. Slade, Ph.D. (formerly of Johns Hopkins University), William Hargreaves, Ph.D., and Martha Shumway, Ph.D., University of California, San Francisco.
Eli Lilly and Company sponsored this study. Dr. Zhu, Dr. Ascher-Svanum, Dr. Faries, and Mr. Montgomery are employees and minor stockholders of Eli Lilly and Company. Dr. Shi received a consulting grant and unrestricted research grants from Eli Lilly and Company. Dr. Marder has received grant support from Eli Lilly and Company and Janssen Pharmaceuticals and is a consultant for Bristol-Myers Squibb, Otsuka American Pharmaceuticals, Solvay Pharmaceuticals, and Pfizer.